Exact Sciences Corporation vs Pfizer, Inc. — Stock Comparison
Q·Score Breakdown
4.7
Bearish
Overall
6.5
Neutral
Quality
Health
Growth
Valuation
Sentiment
EXAS
Healthy balance sheet and financial position.
⚠ currently unprofitable (-6% margin).
PFE
Strong profitability with 12% net profit margins.
⚠ analyst sentiment is cautious.
Analyst Consensus
HOLD
Target $106.30 (+1.3%)
10 analysts
HOLD
Target $29.00 (+10.2%)
27 analysts
Fundamentals
EXAS
PFE
—
Trailing P/E
19.4×
55.2×
Forward P/E
9.4×
-6.4%
Profit Margin
12.4%
69.7%
Gross Margin
75.8%
-8.7%
ROE
8.9%
23.1%
Revenue Growth
-1.2%
—
Earnings Growth
—
1.44
Beta
0.39
—
Price / Book
—
$20.0B
Market Cap
$149.8B
$39 – $105
52-Week Range
$22 – $29
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →